Kubota Pharmaceutical Holdings Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was JPY 2.87 million. Net loss was JPY 1,680.87 million compared to JPY 1,930.57 million a year ago.

Basic loss per share from continuing operations was JPY 35.2 compared to JPY 42.5 a year ago. Diluted loss per share from continuing operations was JPY 35.2 compared to JPY 42.5 a year ago.